ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Allison Gordon

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-1297-123X; OpenAlex author ID A5102874450.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 trial

Papers 1

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes. Co-author DOI 10.1002/cam4.4916 ↗

Trials 1

A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer Principal investigator NCT07895498 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Lilly ChunHong Gu · 1 shared paper, 2023
- Paper Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes. DOI 10.1002/cam4.4916 ↗
Eileen Mary O'Reilly · 1 shared paper, 2023
- Paper Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes. DOI 10.1002/cam4.4916 ↗
Marinela Capanu · 1 shared paper, 2023
- Paper Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes. DOI 10.1002/cam4.4916 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.